newsfilter
← Latest News
Business Wire·

VFMCRP receives EU approval for Tavneos® for the treatment of ANCA-associated vasculitis

First orally administered therapy for the treatment of the two main types of ANCA-associated vasculitis approved in Europe First launches expected in H1 2022 Regulatory News: Vifor Fresenius Medical Care Renal Pharma (VFMCRP) today announc